His primary areas of investigation include Biochemistry, Cytochrome P450, Carcinogen, CYP1B1 and Microsome. Many of his studies involve connections with topics such as Stereochemistry and Biochemistry. Thomas R. Sutter has researched Stereochemistry in several fields, including Quinoline and Pyrene.
The various areas that Thomas R. Sutter examines in his Cytochrome P450 study include Epoxide hydrolase and Benzopyrene. His CYP1B1 study incorporates themes from Cell culture, Gene expression and Hydroxylation. His Microsome study integrates concerns from other disciplines, such as Metabolite, Antibody and Isozyme.
Thomas R. Sutter mainly investigates Biochemistry, Cytochrome P450, CYP1B1, Internal medicine and Endocrinology. In the subject of general Biochemistry, his work in Carcinogen, Enzyme, Reductase and Glutathione is often linked to Aflatoxin, thereby combining diverse domains of study. His Carcinogen study combines topics in areas such as Carcinogenesis and Quinoline.
His research investigates the connection between Enzyme and topics such as Stereochemistry that intersect with problems in Pyrene. His research integrates issues of Microsome, Isozyme, Genetics and Benzopyrene in his study of Cytochrome P450. His CYP1B1 research includes themes of Cell culture, In vitro, Aromatic hydrocarbon receptor, Hydroxylation and Molecular biology.
Thomas R. Sutter mainly focuses on Cell biology, Biochemistry, Keratinocyte, Gene and Aryl hydrocarbon receptor. His work on Signal transduction as part of general Cell biology study is frequently connected to Glucose uptake and Glucose transporter, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Biochemistry study frequently draws connections between related disciplines such as Pharmacology.
His work on Candidate gene and Carcinogenesis is typically connected to Data mining and Trizol as part of general Gene study, connecting several disciplines of science. His studies deal with areas such as S-Nitrosylation, Antimicrobial and Epithelial cell differentiation as well as Aryl hydrocarbon receptor. In Cellular differentiation, Thomas R. Sutter works on issues like Epidermal growth factor, which are connected to Endocrinology.
His primary areas of study are Biochemistry, Molecular biology, Keratinocyte, Regulation of gene expression and Cellular differentiation. His Biochemistry study often links to related topics such as Pharmacology. His Molecular biology research includes elements of Promoter, Gene expression, Aryl hydrocarbon receptor and Hair follicle.
Thomas R. Sutter works mostly in the field of Gene expression, limiting it down to concerns involving Nuclear receptor and, occasionally, Microarray analysis techniques. The Keratinocyte study which covers Function that intersects with Signal transduction. His Regulation of gene expression research is multidisciplinary, incorporating perspectives in Adipose tissue, DNA microarray, KEGG and Kidney transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
Tsutomu Shimada;Carrie L. Hayes;Hiroshi Yamazaki;Shantu Amin.
Cancer Research (1996)
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1
Carrie L. Hayes;David C. Spink;Barbara C. Spink;Joan Q. Cao.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2.
Thomas R. Sutter;Yong Ming Tang;Carrie L. Hayes;Yu Yuan P Wo.
Journal of Biological Chemistry (1994)
Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention ☆
Ercole Cavalieri;Dhubajyoti Chakravarti;Joseph Guttenplan;Elizabeth Hart.
Biochimica et Biophysica Acta (2006)
Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
Mi Kyoung Kwak;Ken Itoh;Masayuki Yamamoto;Thomas R. Sutter.
Molecular Medicine (2001)
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
Tsutomu Shimada;Junko Watanabe;Kaname Kawajiri;Thomas R. Sutter.
Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
James H. Kim;Kevin H. Stansbury;Nigel J. Walker;Michael A. Trush.
Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
D. C. Spink;B. C. Spink;J. Q. Cao;J. A. Depasquale.
Isolation and characterization of the human cytochrome P450 CYP1B1 gene.
Yong Ming Tang;Yu-Yuan P. Wo;Jane Stewart;Anita L. Hawkins.
Journal of Biological Chemistry (1996)
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1, 9(11)-dien-28-oyl]imidazole
Melinda S. Yates;Mi Kyoung Kwak;Patricia A. Egner;John D. Groopman.
Cancer Research (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: